Transbronchial lung biopsy in the compromised host.

Area of Science:

• Pulmonology
• Infectious Diseases
• Critical Care Medicine

Background:

• Immunocompromised patients often present with fever and pulmonary infiltrates.
• Diagnosing the cause of pneumonia in these patients is crucial for effective treatment.

Purpose of the Study:

• To evaluate the diagnostic utility and safety of transbronchial lung biopsy in immunocompromised patients.
• To determine the yield of bronchoscopic lung biopsy for various pulmonary conditions.

Main Methods:

• Thirty-eight immunocompromised patients with fever and pulmonary infiltrates underwent fiberoptic bronchoscopy with transbronchial lung biopsy.
• Diagnostic information was compared between lung biopsy and bronchial brushings.
• The diagnostic yield was analyzed based on the pattern of infiltrates (diffuse vs. localized).

Main Results:

• Transbronchial lung biopsy provided diagnostic information in 76% of patients.
• Infections were diagnosed in 10 cases, and nonspecific interstitial pneumonitis in 13 cases.
• Diffuse infiltrates had a higher diagnostic yield (84%) compared to localized infiltrates (43%).
• Bronchial brushings had a low diagnostic yield (3%).
• The procedure was associated with low morbidity, with four cases of pneumothorax and no deaths.

Conclusions:

• Transbronchial lung biopsy is a safe and effective procedure for evaluating pneumonia in immunocompromised hosts.
• It offers a high diagnostic yield, particularly for diffuse pulmonary infiltrates.
• The low morbidity supports its role in the diagnostic armamentarium for this patient population.